<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19477" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chondroblastoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tafti</surname>
            <given-names>Dawood</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rawla</surname>
            <given-names>Prashanth</given-names>
          </name>
          <aff>Sovah Health, Martinsville, VA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dawood Tafti declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prashanth Rawla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19477.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chondroblastoma is a benign, chondroid-producing neoplasm composed of chondroblasts. It accounts for less than 1% of all bone tumors and usually arises in the epiphyses or apophysis of skeletally immature patients. The treatment of choice of chondroblastoma is surgical. In general, chondroblastoma has a good prognosis, and patients often experience full resolution after surgical treatment. This activity reviews the pathophysiology and presentation of chondroblastoma and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the presentation of chondroblastoma.</p></list-item><list-item><p>Describe the evaluation of a patient suspected of having chondroblastoma.</p></list-item><list-item><p>Summarize the treatment options for chondroblastoma.</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by chondroblastoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19477&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19477">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19477.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chondroblastoma is a benign, chondroid-producing neoplasm composed of chondroblasts. It accounts for less than 1% of all bone tumors and usually arises in the epiphyses or apophysis of skeletally immature patients.<xref ref-type="bibr" rid="article-19477.r1">[1]</xref> Jaffe et al. proposed the term "chondroblastoma," noting the immature chondroid cells and poorly formed matrix.<xref ref-type="bibr" rid="article-19477.r2">[2]</xref> These neoplasms usually occur in the long bones and are important, considering both benign and malignant etiologies in the differential diagnosis. The proximal humerus is the most common site of involvement, followed by the distal femur and proximal femur.<xref ref-type="bibr" rid="article-19477.r3">[3]</xref>&#x000a0;Chondroblastomas require surgical treatment.&#x000a0;In general, chondroblastoma has a good prognosis, and patients often experience full resolution after surgical treatment.</p>
      </sec>
      <sec id="article-19477.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology to include the genetics and environmental factors that predispose patients to the formation of these neoplasms is not well understood. Although researchers have not yet observed a single chromosomal breaking point, they have described various&#x000a0;abnormalities at 2q35, 3q21-23, 8q21, 18q21, p53, chromosome 5, 8, 11, 17 in the literature. <xref ref-type="bibr" rid="article-19477.r4">[4]</xref><xref ref-type="bibr" rid="article-19477.r5">[5]</xref><xref ref-type="bibr" rid="article-19477.r6">[6]</xref><xref ref-type="bibr" rid="article-19477.r7">[7]</xref></p>
      </sec>
      <sec id="article-19477.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Chondroblastoma is a rare benign neoplasm, accounting for&#x000a0;less than 1% of all primary&#x000a0;bone tumors. Most chondroblastomas are diagnosed in the&#x000a0;second to third decade of life (mean age,&#x000a0;19 to 23 years) with a male predominance (2 to 1).<xref ref-type="bibr" rid="article-19477.r1">[1]</xref> More than 75% of cases involve the long bones; the most common anatomical sites are the epiphyseal regions of the proximal and distal femur, proximal tibia, and proximal humerus.<xref ref-type="bibr" rid="article-19477.r8">[8]</xref><xref ref-type="bibr" rid="article-19477.r9">[9]</xref> Rarely clinicians will encounter them in flat bones as or the bones of the hands and feet.<xref ref-type="bibr" rid="article-19477.r10">[10]</xref> Chondroblastomas almost invariably involve a single bone.</p>
      </sec>
      <sec id="article-19477.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Histogenesis:</bold>
</p>
        <p>The histogenesis of chondroblastomas remains controversial. Possible proposed cells of origin include cartilage germ cells or epiphyseal cartilage cells.<xref ref-type="bibr" rid="article-19477.r10">[10]</xref>&#x000a0;A possible multipotent mesenchymal cell or tendon sheath synovial cell origin is another proposed etiological site.&#x000a0;<xref ref-type="bibr" rid="article-19477.r11">[11]</xref></p>
        <p>
<bold>Genetics:</bold>
</p>
        <p>Flow cytometric studies reveal that most chondroblastomas are diploid with low proliferation fractions.<xref ref-type="bibr" rid="article-19477.r12">[12]</xref><xref ref-type="bibr" rid="article-19477.r13">[13]</xref> There are reports of clonal abnormalities in 14 chondroblastomas.<xref ref-type="bibr" rid="article-19477.r14">[14]</xref>&#x000a0; Heterogeneous rearrangements of chromosomes 5 and 8, both balanced and unbalanced, appear to be the most common.&#x000a0;IDH1 and IDH2 mutations are absent.<xref ref-type="bibr" rid="article-19477.r5">[5]</xref> Recently, research has shown that chondroblastomas have distinctive driver mutations in the genes that encode histone H3.3. Chondroblastomas harbor mutations in the H3F3B gene far more commonly&#x000a0;than the H3F3A gene.<xref ref-type="bibr" rid="article-19477.r15">[15]</xref> Research has found an antibody directed against the H3F3 K36M mutation to be specific for chondroblastoma.<xref ref-type="bibr" rid="article-19477.r16">[16]</xref></p>
      </sec>
      <sec id="article-19477.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Macroscopic findings:</bold>
</p>
        <p>Grossly, chondroblastomas appear as multiple pinkish-tan soft tissue fragments that may exhibit areas of calcification, hemorrhage, or cystic changes.</p>
        <p>
<bold>Histopathological findings:</bold>
</p>
        <p>Histologically, a chondroblastoma characteristically presents with a sheet-like proliferation of small to intermediate-sized round polygonal cells.<xref ref-type="bibr" rid="article-19477.r1">[1]</xref> These cells have well-defined cytoplasmic borders, clear to slightly basophilic cytoplasm, and round to ovoid nucleus (chondroblasts). They often exhibit longitudinal grooves and one or more small or inconspicuous nucleoli. Randomly distributed osteoclast-type giant cells are almost always present. Variably-sized nodules of amorphous to eosinophilic material (chondroid) accompany the chondroblasts. Mature hyaline cartilage is relatively uncommon. A fine network of pericellular ''chicken wire'' calcifications is characteristic. Recurrent chondroblastomas may show cytological atypia, which the clinician should not interpret as a sign of malignant transformation.</p>
        <p>
<bold>Immunohistochemical findings:</bold>
</p>
        <p>Immunohistochemically, the chondroblasts are positive for&#x000a0;vimentin, neuron-specific enolase, and S100 protein.<xref ref-type="bibr" rid="article-19477.r1">[1]</xref> Sox9 is a transcriptional factor that shows positivity in&#x000a0;chondroblastomas.<xref ref-type="bibr" rid="article-19477.r17">[17]</xref> DOG1 is a useful marker that helps to distinguish chondroblastoma from other giant cell-containing bone tumors.<xref ref-type="bibr" rid="article-19477.r18">[18]</xref> Observable positivity for keratins, namely 8, 18, and 19 and p63, is frequently in evidence.<xref ref-type="bibr" rid="article-19477.r19">[19]</xref></p>
      </sec>
      <sec id="article-19477.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical complaints are often nonspecific.<xref ref-type="bibr" rid="article-19477.r3">[3]</xref> Symptoms are typically present for many months before the patient seeks medical attention. They include<xref ref-type="bibr" rid="article-19477.r9">[9]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Insidious onset of bone pain: the&#x000a0;most common</p>
          </list-item>
          <list-item>
            <p>Other nonspecific complaints:&#x000a0;local swelling, joint stiffness and/or effusion, and the development of a limp</p>
          </list-item>
          <list-item>
            <p>In tumors arising from the skull bones: seizures and progressive hearing loss can also occur</p>
          </list-item>
        </list>
        <p>Physical examination of patients with chondroblastoma can disclose the following findings<xref ref-type="bibr" rid="article-19477.r1">[1]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Local tenderness</p>
          </list-item>
          <list-item>
            <p>Joint effusion</p>
          </list-item>
          <list-item>
            <p>Decreased range of motion in the affected joint</p>
          </list-item>
          <list-item>
            <p>Muscular atrophy</p>
          </list-item>
          <list-item>
            <p>Rarely: a palpable mass</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19477.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Several imaging modalities are available for establishing the diagnosis of chondroblastoma. They include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Plain radiographs</p>
          </list-item>
          <list-item>
            <p>Computed tomography (CT)</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging (MRI)</p>
          </list-item>
        </list>
        <p>A well-demarcated eccentric and lytic lesion with a thin rim of sclerotic bone is the typical radiologic presentation of chondroblastomas.&#x000a0;Chondroblastomas are relatively small (3 to 6 cm) and occupy less than half of the epiphysis. There is generally no expansion of the bone.</p>
        <p>
<bold>Plain radiographs:</bold>
</p>
        <p>Plain radiographs show a fuzzy, round-to-oval, well-delineated lesion&#x000a0;with a sclerotic rim.<xref ref-type="bibr" rid="article-19477.r20">[20]</xref></p>
        <p>
<bold>Computed tomography:</bold>
</p>
        <p>Computed tomography&#x000a0;can&#x000a0;demonstrate calcifications that&#x000a0;are not detectable on plain radiographs. It&#x000a0;can depict cortical erosion, matrix mineralization, and soft tissue extension.<xref ref-type="bibr" rid="article-19477.r21">[21]</xref></p>
        <p>
<bold>Magnetic resonance imaging:</bold>
</p>
        <p>In chondroblastomas, MRI&#x000a0; demonstrates extensive edema surrounding the lesion. The signal intensity on T1- and T2-weighted MRI images depends&#x000a0;on the levels of various components within the lesion.&#x000a0;Most&#x000a0;cases show variable intensity on T2-weighted images.<xref ref-type="bibr" rid="article-19477.r22">[22]</xref></p>
      </sec>
      <sec id="article-19477.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of choice of chondroblastoma is surgical. It consists of complete surgical curettage with or without bone grafting, en bloc resection, or rarely, amputation. Surgical&#x000a0;resection alleviates pain, avoids propagation&#x000a0;into the joint and adjacent soft tissues,&#x000a0;diminishes the&#x000a0;likelihood of recurrence, and accurately establishes the diagnosis of&#x000a0;chondroblastomas.&#x000a0; Surgical management depends on<xref ref-type="bibr" rid="article-19477.r23">[23]</xref><xref ref-type="bibr" rid="article-19477.r24">[24]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>The extent of bone and/or joint involvement</p>
          </list-item>
          <list-item>
            <p>Anatomic location of the lesion</p>
          </list-item>
          <list-item>
            <p>Staging</p>
          </list-item>
        </list>
        <p>Stage 1 (latent) or stage 2 (active) may be an indication for intralesional excision.</p>
        <p>Stage 3 (aggressive) is an indication of marginal or wide resection.<xref ref-type="bibr" rid="article-19477.r24">[24]</xref></p>
        <p>Adjunctive therapy includes&#x000a0;chemical cauterization with phenol or cryosurgery. Bone grafting and cryotherapy after surgical curettage decrease the risk of recurrence.<xref ref-type="bibr" rid="article-19477.r1">[1]</xref> Some authors suggest that&#x000a0;radiofrequency&#x000a0;should be an option as an alternative treatment method in managing chondroblastomas.<xref ref-type="bibr" rid="article-19477.r10">[10]</xref> There is no definite role for adjuvant chemotherapy or radiotherapy.&#x000a0;For recurrent tumors, resection remains the treatment of choice.<xref ref-type="bibr" rid="article-19477.r1">[1]</xref></p>
      </sec>
      <sec id="article-19477.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for chondroblastomas chiefly includes other epiphyseal lesions. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Giant cell tumor of bone</p>
          </list-item>
          <list-item>
            <p>Geode or intraosseous ganglion</p>
          </list-item>
          <list-item>
            <p>Clear cell chondrosarcoma</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis</p>
          </list-item>
        </list>
        <p>Other differentials that are possible include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Osteosarcoma</p>
          </list-item>
          <list-item>
            <p>Osteoblastoma</p>
          </list-item>
          <list-item>
            <p>Brown tumor</p>
          </list-item>
          <list-item>
            <p>Osteoid osteoma</p>
          </list-item>
          <list-item>
            <p>Aneurysmal bone cyst</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19477.s11" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>The complications of surgical treatment include<xref ref-type="bibr" rid="article-19477.r10">[10]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Damage of&#x000a0;the articular cartilage or even an open growth plate&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recurrence in surgically treated patients&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hematoma</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Fracture</p>
          </list-item>
          <list-item>
            <p>Limb-length discrepancy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19477.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>If left untreated, chondroblastoma&#x000a0;does not undergo spontaneous regression.&#x000a0; Recurrence rates of chondroblastomas range from 8.3% to 21.4% and may be explainable by retained tumor material&#x000a0;during surgery.<xref ref-type="bibr" rid="article-19477.r25">[25]</xref><xref ref-type="bibr" rid="article-19477.r26">[26]</xref> The risk of recurrence increases in case of inadequate surgery, location in the hip and pelvis, young age, and aneurysmal bone cyst components.<xref ref-type="bibr" rid="article-19477.r27">[27]</xref> Rarely,&#x000a0;pulmonary metastases occur from histologically benign chondroblastomas. However, these metastases are clinically nonprogressive and treatable by surgical resection or simple observation.<xref ref-type="bibr" rid="article-19477.r28">[28]</xref> Malignant transformation of a chondroblastoma is extremely rare. There are no reliable histological parameters capable of predicting more aggressive behavior.</p>
      </sec>
      <sec id="article-19477.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The most common complication associated with chondroblastoma is local recurrence after surgery. Patients require long term monitoring post-surgery&#x000a0;for any recurrence of the tumor.<xref ref-type="bibr" rid="article-19477.r29">[29]</xref><xref ref-type="bibr" rid="article-19477.r26">[26]</xref> Pathological fractures can also occur. Rarely, a malignant transformation may take place, as documented in a few case reports.<xref ref-type="bibr" rid="article-19477.r30">[30]</xref><xref ref-type="bibr" rid="article-19477.r31">[31]</xref></p>
      </sec>
      <sec id="article-19477.s14" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Orthopedics: treatment for chondroblastoma almost always involves surgery with intralesional curettage and packing.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19477.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Chondroblastoma is mostly a benign bone tumor, and patients and their families need education on how to recognize the early signs and symptoms of bone tumors. Patients with signs of bone pain, swelling of bones or joints, any palpable mass found on the bones, fractures not associated with trauma should seek early intervention. Treatment for chondroblastoma is predominantly surgical. Prognosis is usually good once treated. Local recurrence can occur after surgery, and rarely malignant transformation has been reported. Long term follow-up is necessary to monitor these patients closely. The interdisciplinary team includes orthopedics, oncologists, and specialty care nurses. Prompt diagnosis by primary providers with a referral for treatment is paramount. Specialty trained nurses in orthopedics assist in coordinating care, monitoring patients, arrange for follow up, and report problems to the team.</p>
      </sec>
      <sec id="article-19477.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chondroblastoma is&#x000a0;ideally managed&#x000a0;by an interprofessional team that consists of&#x000a0;orthopedists, radiologists, and pathologists. Correlation between gross, radiographic, and microscopic features of the lesion is crucial to establish the definitive diagnosis of chondroblastoma. Postoperatively, patients require long term follow-up due to the possibility of tumor recurrence.</p>
      </sec>
      <sec id="article-19477.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19477&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19477">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/chondroblastoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19477">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19477/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19477">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19477.s18">
        <fig id="article-19477.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Chondroblastoma Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chondroblastoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19477.s19">
        <fig id="article-19477.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Radiographic image of a lytic lesion primarily centered at the epiphysis. Contributed by Dr.Dawood Tafti</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chondroblastoma5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19477.s20">
        <fig id="article-19477.image.f3" position="float" orientation="portrait">
          <caption>
            <p>MRI image of an epiphyseal lesion. Contributed by Dawood Tafti, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chondroblsatoma__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19477.s21">
        <fig id="article-19477.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Coronal CT demonstrates a lytic lesion within the physis/epiphysis of the distal femur. Contributed by Dawood Tafti, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chondroblastoma3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19477.s22">
        <fig id="article-19477.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Coronal T2/STIR image of the left knee. Contributed by Dawood Tafti, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chondroblastoma1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19477.s23">
        <title>References</title>
        <ref id="article-19477.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>DiFrancesco</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma: An Update.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>141</volume>
            <issue>6</issue>
            <fpage>867</fpage>
            <page-range>867-871</page-range>
            <pub-id pub-id-type="pmid">28557595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaffe</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Benign Chondroblastoma of Bone: A Reinterpretation of the So-Called Calcifying or Chondromatous Giant Cell Tumor.</article-title>
            <source>Am J Pathol</source>
            <year>1942</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>969</fpage>
            <page-range>969-91</page-range>
            <pub-id pub-id-type="pmid">19970672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dahlin</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Ivins</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Benign chondroblastoma. A study of 125 cases.</article-title>
            <source>Cancer</source>
            <year>1972</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>401</fpage>
            <page-range>401-13</page-range>
            <pub-id pub-id-type="pmid">5051664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Mattos</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Angsanuntsukh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arkader</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dormans</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma and chondromyxoid fibroma.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>225</fpage>
            <page-range>225-33</page-range>
            <pub-id pub-id-type="pmid">23545728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sj&#x000f6;gren</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Orndal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tingby</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Meis-Kindblom</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kindblom</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Stenman</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.</article-title>
            <source>Int J Oncol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1385</fpage>
            <page-range>1385-91</page-range>
            <pub-id pub-id-type="pmid">15138578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swarts</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Neff</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bridge</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1998</year>
            <month>Apr</month>
            <issue>349</issue>
            <fpage>189</fpage>
            <page-range>189-93</page-range>
            <pub-id pub-id-type="pmid">9584382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostrowski</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Truong</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Hicks</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Spjut</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Malignant chondroblastoma presenting as a recurrent pelvic tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy.</article-title>
            <source>Skeletal Radiol</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>644</fpage>
            <page-range>644-50</page-range>
            <pub-id pub-id-type="pmid">10591928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bloem</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma: a clinical and radiological study of 104 cases.</article-title>
            <source>Skeletal Radiol</source>
            <year>1985</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">4023729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turcotte</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Kurt</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Unni</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma.</article-title>
            <source>Hum Pathol</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>944</fpage>
            <page-range>944-9</page-range>
            <pub-id pub-id-type="pmid">8253461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petsas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Megas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Papathanassiou</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Radiofrequency ablation of two femoral head chondroblastomas.</article-title>
            <source>Eur J Radiol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>63</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-7</page-range>
            <pub-id pub-id-type="pmid">17482405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brien</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Mirra</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ippolito</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma arising from a nonepiphyseal site.</article-title>
            <source>Skeletal Radiol</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>220</fpage>
            <page-range>220-2</page-range>
            <pub-id pub-id-type="pmid">7610417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>el-Naggar</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Hurr</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>ZN</given-names>
              </name>
              <name>
                <surname>Teague</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ayala</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.</article-title>
            <source>Cytometry</source>
            <year>1995</year>
            <month>Mar</month>
            <day>01</day>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>256</fpage>
            <page-range>256-62</page-range>
            <pub-id pub-id-type="pmid">7736870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarkkanen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nordling</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hling</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kivioja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karaharju E Szymanska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elomaa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Knuutila</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors.</article-title>
            <source>Cytometry</source>
            <year>1996</year>
            <month>Sep</month>
            <day>15</day>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>185</fpage>
            <page-range>185-91</page-range>
            <pub-id pub-id-type="pmid">8889389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mark</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wedell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dahlenfors</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grepp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burian</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Human benign chondroblastoma with a pseudodiploid stemline characterized by a complex and balanced translocation.</article-title>
            <source>Cancer Genet Cytogenet</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-7</page-range>
            <pub-id pub-id-type="pmid">1728944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Behjati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tarpey</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Presneau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Scheipl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pillay</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Van Loo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wedge</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Gundem</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nik-Zainal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McLaren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goodie</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Teague</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Halai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Khatri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Myklebost</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Baumhoer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jundt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hamoudi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tirabosco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Amary</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Futreal</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Stratton</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Flanagan</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.</article-title>
            <source>Nat Genet</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>12</issue>
            <fpage>1479</fpage>
            <page-range>1479-82</page-range>
            <pub-id pub-id-type="pmid">24162739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amary</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Berisha</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mozela</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guttridge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baumhoer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tirabosco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Flanagan</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.</article-title>
            <source>Histopathology</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-7</page-range>
            <pub-id pub-id-type="pmid">26844533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Konishi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iwasa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yanagisawa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.</article-title>
            <source>Hum Pathol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>208</fpage>
            <page-range>208-13</page-range>
            <pub-id pub-id-type="pmid">19801163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akpalo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zustin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.</article-title>
            <source>Histopathology</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>60</volume>
            <issue>7</issue>
            <fpage>1099</fpage>
            <page-range>1099-106</page-range>
            <pub-id pub-id-type="pmid">22335248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Semmelink</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Pruszczynski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wiersma-van Tilburg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smedts</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ramaekers</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Cytokeratin expression in chondroblastomas.</article-title>
            <source>Histopathology</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>257</fpage>
            <page-range>257-63</page-range>
            <pub-id pub-id-type="pmid">1692005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clapper</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>DeYoung</surname>
                <given-names>BR</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma of the femoral diaphysis: report of a rare phenomenon and review of literature.</article-title>
            <source>Hum Pathol</source>
            <year>2007</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>803</fpage>
            <page-range>803-6</page-range>
            <pub-id pub-id-type="pmid">17306329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma in the long bone diaphysis: a report of two cases with literature review.</article-title>
            <source>Chin J Cancer</source>
            <year>2012</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>257</fpage>
            <page-range>257-64</page-range>
            <pub-id pub-id-type="pmid">22464651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oxtoby</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>MRI characteristics of chondroblastoma.</article-title>
            <source>Clin Radiol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-6</page-range>
            <pub-id pub-id-type="pmid">8549042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;zer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ar&#x00131;kan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>G&#x000fc;r</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>G&#x000f6;k</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Akman</surname>
                <given-names>YE</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment.</article-title>
            <source>Acta Orthop Traumatol Turc</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>415</fpage>
            <page-range>415-418</page-range>
            <pub-id pub-id-type="pmid">30249436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arguedas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Varela</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruggieri</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Chondroblastoma of the Foot: 40 Cases From a Single Institution.</article-title>
            <source>J Foot Ankle Surg</source>
            <year>2018</year>
            <season>Nov-Dec</season>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>1105</fpage>
            <page-range>1105-1109</page-range>
            <pub-id pub-id-type="pmid">30368424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Thenappan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deavers</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>VO</given-names>
              </name>
              <name>
                <surname>Yasko</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Treatment and prognosis of chondroblastoma.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>438</volume>
            <fpage>103</fpage>
            <page-range>103-9</page-range>
            <pub-id pub-id-type="pmid">16131877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atalar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Basarir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Erekul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saglik</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Management of chondroblastoma: retrospective review of 28 patients.</article-title>
            <source>J Orthop Sci</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>334</fpage>
            <page-range>334-40</page-range>
            <pub-id pub-id-type="pmid">17657552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hapa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Karaka&#x0015f;l&#x00131;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demirk&#x00131;ran</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Akdeniz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Havit&#x000e7;io&#x0011f;lu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Operative treatment of chondroblastoma: a study of 11 cases.</article-title>
            <source>Acta Orthop Belg</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-71</page-range>
            <pub-id pub-id-type="pmid">26984656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riddell</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Louis</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Bromberger</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary metastases from chondroblastoma of the tibia. Report of a case.</article-title>
            <source>J Bone Joint Surg Br</source>
            <year>1973</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>848</fpage>
            <page-range>848-53</page-range>
            <pub-id pub-id-type="pmid">4766191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sailhan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chotel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Parot</surname>
                <given-names>R</given-names>
              </name>
              <collab>SOFOP</collab>
            </person-group>
            <article-title>Chondroblastoma of bone in a pediatric population.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>91</volume>
            <issue>9</issue>
            <fpage>2159</fpage>
            <page-range>2159-68</page-range>
            <pub-id pub-id-type="pmid">19723993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duttaluri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sultanpurkar</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Raorane</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vikram</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Malignant chondroblastoma of extraskeletal origin.</article-title>
            <source>Int J Appl Basic Med Res</source>
            <year>2016</year>
            <season>Apr-Jun</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>146</fpage>
            <page-range>146-8</page-range>
            <pub-id pub-id-type="pmid">27127749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19477.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyriakos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Land</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Penning</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Metastatic chondroblastoma. Report of a fatal case with a review of the literature on atypical, aggressive, and malignant chondroblastoma.</article-title>
            <source>Cancer</source>
            <year>1985</year>
            <month>Apr</month>
            <day>15</day>
            <volume>55</volume>
            <issue>8</issue>
            <fpage>1770</fpage>
            <page-range>1770-89</page-range>
            <pub-id pub-id-type="pmid">3978565</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
